COWA LLC’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,218
Closed -$231K – 188
2026
Q2
$231K Sell
1,218
-16
-1% -$3.01K 0.06% 167
2026
Q1
$243K Sell
1,234
-1
-0.1% -$193 0.07% 141
2025
Q4
$227K Buy
+1,235
New +$217K 0.07% 144
2024
Q1
– Sell
-1,600
Closed -$216K – 121
2023
Q4
$216K Sell
1,600
-2,000
-56% -$260K 0.13% 106
2023
Q3
$488K Sell
3,600
-690
-16% -$94.2K 0.33% 57
2023
Q2
$614K Sell
4,290
-17,278
-80% -$2.54M 0.4% 54
2023
Q1
$575K Buy
21,568
+17,218
+396% +$2.32M 0.47% 53
2022
Q4
$636K Sell
4,350
-510
-10% -$64K 0.4% 55
2022
Q3
$534K Buy
4,860
+550
+13% +$69.8K 0.35% 61
2022
Q2
$569K Hold
4,310
– – 0.33% 68
2022
Q1
$572K Hold
4,310
– – 0.28% 69
2021
Q4
$502K Buy
4,310
+50
+1% +$5.88K 0.25% 71
2021
Q3
$512K Sell
4,260
-225
-5% -$26.2K 0.29% 67
2021
Q2
$541K Buy
4,485
+210
+5% +$23K 0.34% 56
2021
Q1
$427K Buy
4,275
+580
+16% +$58.3K 0.26% 68
2020
Q4
$375K Buy
+3,695
New +$391K 0.29% 68

Other funds holding AZN

COWA LLC's AZN Position: Q3 2026 in Review

COWA LLC sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,218 shares — an estimated $231K sold.

COWA LLC first reported a position in AZN in Q4 2020 and held it in 16 quarters. The position peaked at $636K in Q4 2022. 635 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • COWA LLC reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
  • COWA LLC sold 1,218 AstraZeneca shares in Q3 2026, an estimated $231K.
  • COWA LLC first reported a position in AstraZeneca in Q4 2020 and held it in 16 quarters.
  • COWA LLC's AstraZeneca position peaked at $636K in Q4 2022.
  • 635 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on COWA LLC's 13F filing for Q3 2026, filed 30 Oct 2026.